<--- Back to Details
First PageDocument Content
Economy / Pharmaceutical industry / Pharmaceuticals policy / Business / Marketing authorization / Packaging and labeling / Quality management system
Date: 2015-05-29 10:18:53
Economy
Pharmaceutical industry
Pharmaceuticals policy
Business
Marketing authorization
Packaging and labeling
Quality management system

CMDh meeting with representative of Interested Parties 19 May 2015  Type IA variation label implementation guidance.

Add to Reading List

Source URL: www.hma.eu

Download Document from Source Website

File Size: 756,54 KB

Share Document on Facebook

Similar Documents

TIGes vet Q&A-update - Sept 2013

TIGes vet Q&A-update - Sept 2013

DocID: 1rsZK - View Document

BPGWorksharingEMA-CMDv

BPGWorksharingEMA-CMDv

DocID: 1rr9m - View Document

CMDh meeting with representative of Interested Parties 19 May 2015  Type IA variation label implementation guidance.

CMDh meeting with representative of Interested Parties 19 May 2015  Type IA variation label implementation guidance.

DocID: 1rqES - View Document

Pharmaceutical industry / Medical research / Clinical data management / Clinical research / Health care / Evaluation / Validity / Quality / Validation / Marketing authorization / Electronic submission

Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions <> "Error*"Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions \* MERGEFORMAT Annex VI: Imple

DocID: 1rqtS - View Document

Quasi Drug Rules in Japan December 2011 Quasi-drugs are a unique product classification in Japan. A quasi-drug is defined in Japan as products that have minimal to moderate pharmacologic activity but are restricted in us

Quasi Drug Rules in Japan December 2011 Quasi-drugs are a unique product classification in Japan. A quasi-drug is defined in Japan as products that have minimal to moderate pharmacologic activity but are restricted in us

DocID: 1rpxR - View Document